A list of publications indexed in Journal Citation Reports and other scientific issues related to the group.
The ISFG aims to promote scientific knowledge in the field of genetic markers as applied to forensic science.
This is mainly being achieved through regular meetings of either regional or international nature, our journal Forensic Science International: Genetics and the work of our expert DNA commissions. Click here to see the list of awardees of the ISFG.
The ISFG has been founded in Mainz, Germany by a group of dedicated blood group serologists in 1968 under the name of "Society for Forensic Haemogenetics" , to address the growing knowledge about polymorphic markers in human blood and their use in paternity testing as well as in forensic stain analysis. Since then, the society has grown rapidly, and has become an international society in the 1980's, carrying the acronym "ISFH". Due to the overwhelming success of DNA-based molecular genetic typing methods, the name was changed again in 1999 to include the more general term "genetics" instead of the original "haemogenetics", since DNA can be extracted from virtually all human tissues and body fluids carrying nucleated cells, resulting in the current name "ISFG".
Today, the society represents more than 1,200 members from over 60 countries from academic and government laboratories, as well as from private companies. Their expertise includes molecular genetics, blood group serology, mathematics and biostatistics, as well as legal matters ranging from criminal law to medical ethics. International congresses are held every two years, and further meetings are organized by the mostly language-based working groups, to address specific topics at the local level. Since 1989, the DNA Commission of the ISFG has published numerous recommendations addressing important topics to help establishing scientific standards in particular for new typing methods and genetic marker systems. Thus the society has adopted a pivotal role to take up the generally accepted scientific knowledge in the field of forensic genetics and condense it into specific guidelines with the overall aim to harmonize the important work derived from the studies of genetic markers in humans for the judicial system.
Zendal, the corporate brand of our group, draws together seven companies focused on research, development, manufacture and marketing of high added value products in the health sector.
The International Zendal Awards aim to disseminate, promote and reward knowledge and research in the field of biotechnology worldwide.
Zendal’s mission is to contribute to the improvement of living conditions through research and development of medicines and vaccines for the prevention of diseases to human beings as well as animals. With this aim the group call the International Zendal Awards to divulge, dynamise and reward knowledge and research within the field of biotechnology worldwide.
(Spanish Society of Pediatric Infectology) for the publication: Martinón-Torres F*, Salas A*, Rivero-Calle I*, Cebey-López M*, Pardo-Seco J*, Herberg JA*, Boeddha NP, Klobassa DS, Secka F, Paulus S, Schlapbach LJ, Driessen GJ, Anderson ST, Emonts M, Zenz W, Carrol ED, Levin M*, EUCLIDS Consortium (2018). Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study. The Lancet. Child & adolescent health; 2:404-414. *Equal contribution
See Special issue: Host Infectomics in the Childhood; Editor: Antonio Salas
Despite the availability of new vaccines and antibacterial agents suppressing microbial pathogens, infectious diseases are among the leading cause of morbidity and mortality worldwide. While there are a number of studies dealing with infections in adults (mainly focused on some particular diseases, e.g., tuberculosis) and/or pathogens, less attention has been devoted to the pediatric age. To overcome this deficiency, several international consortia have emerged in the last decade aimed at investigating life-threatening infections affecting childhood.
‘Omic’ sciences are gaining growing attention in parallel with the development of new and cost-effective technologies, but also bioinformatic and mathematical solutions that allow dealing with big data from massive genotyping and sequencing technologies. The field of infectiology is one of the many in biomedicine that is benefiting from these new achievements, and in particular, the area studying host response to infection from different ‘omic’ perspectives, namely, host infectomics. Thus, there is now increasing evidence supporting that it is not only the pathogen that decides how and when to infect the host, but also the biological predisposition of the host to be infected by the pathogen. Most of the genomic studies published to date have focused their attention on genomics, first by exploring a few thousands of single nucleotide polymorphisms (SNPs) distributed throughout the whole genome in large case-control samples (e.g., population-based genome-wide association studies; GWAS), and more recently using parallel sequencing procedures (e.g., whole exome sequencing, WES). There are also interesting attempts in the terrain of transcriptomic, using microarrays and more recently RNAseq, to investigate the host genetic expression response to different infections and pathogens.
Other selected publications not indexed in Journal Citation Reports (JCR)
Several metrics related to our research activity:
PeerJ — the Journal of Life and Environmental Sciences is a peer-reviewed & Open Access journal publishing primary research and reviews in biology, life sciences, environmental sciences, and medicine.
Forensic Science International: Genetics is the premier journal in the field of Forensic Genetics. This branch of Forensic Science can be defined as the application of geneticsto human and non-human material (in the sense of a science with the purpose of studying inherited characteristics for the analysis of inter- and intra-specific variations in populations) for the resolution of legal conflicts.
IJMS is an international peer-reviewed open access journal providing an advanced forum for biochemistry, molecular and cell biology, molecular biophysics, molecular medicine, and all aspects of molecular research in chemistry, and is published semi-monthly online by MDPI.